High-dose melphalan (Alkeran) and autologous stem cell transplantation are commonly incorporated into the initial line of therapy for patients newly diagnosed with multiple myeloma.
Edward A. Stadtmauer, MD
Advertisement
Articles by Edward A. Stadtmauer, MD
Advertisement
Latest Updated Articles
- Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma
Published: March 15th 2010 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – December 12, 2025
2
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
3
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
4
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
5
